Daily non-political popular news in brief.

Newly found sensing system enables certain bacteria to resist human immune defenses

06-07-2007 · EurekAlert!

Researchers at the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, have discovered a survival mechanism in a common type of bacteria that can cause illness. The mechanism lets the bacteria protect itself by warding off attacks from antimicrobial peptides, which are defense molecules sent by the body to kill bacteria.

Keywords: newly, sensing, system, enables, certain, bacteria, resist, human, immune, defenses, enable, defense

« Previous | Next »

Similar news on "Newly found sensing system enables certain bacteria to resist human immune defenses":

Cornell researcher seeks clues to how tuberculosis infects cells
12-21-2007 · EurekAlert!
Cornell researchers are using advanced genetic techniques to better understand the relationship between the bacteria that cause tuberculosis and the human immune system defense cells that engulf them.
Similar news · Read more »
Immune system protein starves 'staph' bacteria
02-14-2008 · EurekAlert!
A multi-disciplinary team led by Vanderbilt University investigators has discovered that a protein inside certain immune system cells blocks the growth of "staph" bacteria by sopping up manganese and zinc.The findings, reported Feb. 15 in Science, support the notion that binding metals -- to starve bacteria -- is a viable therapeutic option for treating localized bacterial infections. New treatments are urgently needed to combat antibiotic-resistant forms of staph, such as MRSA.
Similar news · Read more »
Staphylococcus aureus hides out in cells
06-14-2007 · EurekAlert!
A major cause of human and animal infections, Staphylococcus aureus bacteria may evade the immune system's defences and dodge antibiotics by climbing into our cells and then lying low to avoid detection. New research in the online open access journal BMC Genomics shows how S. aureus makes itself at home in human lung cells for up to two weeks.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Team IDs weakness in anthrax bacteria
01-22-2008 · Massachusetts Institute of Technology (MIT)
MIT and New York University researchers have identified a weakness in the defenses of the anthrax bacterium--its dependence on nitric oxide to resist the body's immune response--that could be exploited to produce new antibiotics.
Similar news · Read more »
Deadly virus strips away immune system's defensive measures
12-12-2007 · EurekAlert!
When the alert goes out that a virus has invaded the body, cells that have yet to be attacked prepare by "armoring" themselves for combat, attaching specific antiviral molecules to many of their own proteins to help resist the invader. Unfortunately, the deadly Crimean Congo hemorrhagic fever virus knows a simple but devastating way around this defense: just cut the armor off host cell proteins.
Similar news · Read more »
Why doesn't the immune system attack the small intestine?
01-09-2007 · EurekAlert!
Answering one of the oldest questions in human physiology, researchers at Dana-Farber Cancer Institute have discovered why the body's immune system -- perpetually on guard against foreign microbes like bacteria -- doesn't attack tissues in the small intestine that harbor millions of bacteria cells.
Similar news · Read more »
How plague-causing bacteria disarm host defense
05-24-2007 · EurekAlert!
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system. In essence, they knock down the front door of resistance and disarm the cell's alarm system.
Similar news · Read more »
Toxic shock: immune system's anthrax link
08-23-2007 · EurekAlert!
Human immune proteins crucial for fighting cancer, viruses and bacterial infections belong to an ancient and lethal toxin family previously only found in bacteria, Australian researchers have found.
Similar news · Read more »
Researchers learn why immune system's watch dogs howl
08-02-2007 · EurekAlert!
A class of proteins known as toll-like receptors are the guard dogs of the immune system, sniffing out bacteria or viruses then rousing the rest of the immune system for attack. Because of their ability to activate the body's defenses, toll-like receptors are a darling of drug developers. New research led by Brown University immunologist Wen-Ming Chu, M.D., identifies what protein alerts toll-like receptor 9, one of the most powerful guard dogs in the pack.
Similar news · Read more »